AAO 2020: How not to be afraid of performing a posterior capsulorhexis

Conference|AAO

Prof. Marie-José Tassignon, past chief and chair, Department of Ophthalmology, Antwerp University and University Hospital Antwerp, Belgium, expands on her AAO presentation by providing an overview of her novel technique in performing a risk-free posterior capsulorhexis.


Prof. Marie-José Tassignon, past chief and chair, Department of Ophthalmology, Antwerp University and University Hospital Antwerp, Belgium, expands on her upcoming AAO presentation by providing an overview of her novel technique in performing a risk-free posterior capsulorhexis.

Related Videos
Related Content

Ophthalmologists on front lines of identifying victims of intimate partner violence through ocular trauma

May 23rd 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

ARVO 2023: Clearside Biomedical presents data on suprachoroidal injection delivery platform

April 30th 2023

What to expect from virtual AAO 2020

November 5th 2020

ARVO 2023: Nanoscope Therapeutics presents data on MCO-010, an optogenetic therapy for vision restoration in advanced retinitis pigmentosa

April 29th 2023

ARVO 2023: Preclinical data for Ashvattha Therapeutics anti-VEGF nanomedicine D-4517.2 shared at annual meeting

April 28th 2023

Ophthalmologists on front lines of identifying victims of intimate partner violence through ocular trauma

May 23rd 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

ARVO 2023: Clearside Biomedical presents data on suprachoroidal injection delivery platform

April 30th 2023

What to expect from virtual AAO 2020

November 5th 2020

ARVO 2023: Nanoscope Therapeutics presents data on MCO-010, an optogenetic therapy for vision restoration in advanced retinitis pigmentosa

April 29th 2023

ARVO 2023: Preclinical data for Ashvattha Therapeutics anti-VEGF nanomedicine D-4517.2 shared at annual meeting

April 28th 2023

Ophthalmologists on front lines of identifying victims of intimate partner violence through ocular trauma

May 23rd 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

ARVO 2023: Clearside Biomedical presents data on suprachoroidal injection delivery platform

April 30th 2023

What to expect from virtual AAO 2020

November 5th 2020

ARVO 2023: Nanoscope Therapeutics presents data on MCO-010, an optogenetic therapy for vision restoration in advanced retinitis pigmentosa

April 29th 2023

ARVO 2023: Preclinical data for Ashvattha Therapeutics anti-VEGF nanomedicine D-4517.2 shared at annual meeting

April 28th 2023
© 2023 MJH Life Sciences

All rights reserved.